{"id":48425,"date":"2022-09-15T14:02:09","date_gmt":"2022-09-15T12:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/"},"modified":"2022-09-15T14:02:09","modified_gmt":"2022-09-15T12:02:09","slug":"applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/","title":{"rendered":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox"},"content":{"rendered":"
\n

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc.<\/a> (NasdaqCM: AUVI<\/a>) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (\u201cUVC\u201d) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen’s<\/a> Airocide\u00ae<\/a> and Lumicide are highly effective, differentiating solutions for addressing recent recommendations from the Centers for Disease Control (CDC) for cleaning and disinfecting settings that may be contaminated with Monkeypox and other orthopoxviruses.\n<\/p>\n

\nIn a recent publication, available here<\/a>, the CDC provided considerations for disinfecting settings that may be contaminated with Monkeypox virus and highlighted the virus\u2019 sensitive to UV light, disinfectants and household cleaners in a tweet available here<\/a>.\n<\/p>\n

\nJohn F. Andrews Applied UV\u2019s CEO and Director stated, \u201cAs the only public, pure-play air and surface disinfection company, we are uniquely capable of capturing a significant portion of the emerging market opportunity affirmed by the CDC\u2019s recommendations. We have a growing list of business case uses for global, highly recognized customers such as Whole Foods, Del Monte, the Boston Red Sox, Opus One and Tru Infusion, across a diversity of vertical markets including healthcare, cannabis, correctional facilities, schools, wineries, dairy and food preservation that use our Airocide product suite and attest to its efficacy. The emergence of Monkeypox, which is an airborne and surface transmitted pathogen, presents an additional opportunity for us to apply our clinically-proven Airocide<\/a> and Lumicide technologies to eradicate the virus from virtually any contaminated setting and reduce the risk of spread. Independent research has affirmed that orthopoxviruses, including Monkeypox, can survive in an environment for weeks or months and porous materials may harbor live viruses for longer periods of time. Airocide, which was developed for NASA and the University of Wisconsin at Madison, is more effective than ultra-violet (UV) solutions as it utilizes Photocatalytic Oxidation (PCO) technology to completely trap and destroy any and all carbon-based airborne viruses by oxidation without any harmful by-products, and our patented Lumicide surface and drain UVC technology will destroy any surface related Monkeypox virus. We are encouraged by the CDC\u2019s proactive efforts to provide guidance on ways to clean, disinfect and reduce the risk of spread, and we look forward to applying our industry-leading solution to help keep people healthy and safe.\u201d\n<\/p>\n

\nAirocide\u00ae System<\/b>\n<\/p>\n

\nThe Airocide\u00ae<\/a> System, originally developed for NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide\u00ae technology is clinically proven and field tested to kill\/remove\/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate, schools, dental offices and homes. Airocide\u00ae air purifiers are available at www.airocide.com<\/a>.\n<\/p>\n

\nFollow us on Twitter<\/a>
Follow us on LinkedIn<\/a>\n<\/p>\n

\nAbout Applied UV<\/b>\n<\/p>\n

\nApplied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries – SteriLumen, Inc. (\u201cSteriLumen\u201d) and Munn Works, LLC (\u201cMunn Works\u201d). SteriLumen\u2019s connected platform for Data Driven Disinfection\u2122 applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections (“HAIs”). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company\u2019s Lumicide\u2122 platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices\u2019 proximity. The Company\u2019s patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen\u2019s Airocide\u00ae air purification devices are research backed, clinically proven and developed for NASA with assistance from the University of Wisconsin. Airocide\u00ae is listed as an FDA Class II Medical device, utilizes a proprietary photocatalytic (PCO) bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide\u00ae applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities and homes. For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https:\/\/www.applieduvinc.com\/<\/a>\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThe information contained herein may contain \u201cforward\u2010looking statements.\u201d Forward\u2010looking statements reflect the current view about future events. When used in this press release, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cplan,\u201d or the negative of these terms and similar expressions, as they relate to us or our management, identify forward\u2010looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward\u2010looking statements are based on the Company\u2019s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward\u2013looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company\u2019s actual results may differ materially from those contemplated by the forward\u2010looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward\u2010looking statements. Factors or events that could cause the Company\u2019s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward\u2010looking statements to conform these statements to actual results.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor additional Company Information:<\/b>
Applied UV Inc.
\n
John F. Andrews
\n
Applied UV CEO, Director
\n
john.andrews@applieduvinc.com<\/a>\n<\/p>\n

\nContact:<\/b>
Brett Maas, Managing Principal
\n
Hayden IR
\n
brett@haydenir.com<\/a>
(646) 536-7331\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (\u201cUVC\u201d) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen’s Airocide\u00ae and Lumicide are … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48425","6":"format-standard","7":"category-industry"},"yoast_head":"\nApplied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (\u201cUVC\u201d) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen’s Airocide\u00ae and Lumicide are ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T12:02:09+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox\",\"datePublished\":\"2022-09-15T12:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/\"},\"wordCount\":1074,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/\",\"name\":\"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-09-15T12:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/","og_locale":"en_US","og_type":"article","og_title":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend","og_description":"MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (\u201cUVC\u201d) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen’s Airocide\u00ae and Lumicide are ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-15T12:02:09+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox","datePublished":"2022-09-15T12:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/"},"wordCount":1074,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/","url":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/","name":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-09-15T12:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-uvs-airocide-and-lumicide-address-cdcs-recommendation-for-handling-environments-contaminated-by-monkeypox\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied UV\u2019s Airocide\u00ae and Lumicide Address CDC\u2019s Recommendation for Handling Environments Contaminated by Monkeypox"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48425"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48425\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}